Klein v. General Nutrition Companies, Inc.Klein v. General Nutrition Companies, Inc.
OPINION OF THE COURT
Aрpellants are individuals who purchased shares of General Nutrition Companies, Inc. (“GNC”) common stock between a February 7, 1996 public offering (the “public offering”) and May 28, 1996. Appellants filed this class action lawsuit in August 1996, alleging violations of federal securities laws and state law. Appellants assert that the defendants failed to disclose material adverse facts сoncerning GNC’s operations and, as a result, appellants purchased their stock at artificially inflated prices. The suit named three general groups of defendants. The first group (the “GNC defendants”) consisted of GNC and several of its officers. GNC sold 1,635,834 shares in the public offering, realizing net proceeds of $33,939,466. The second group, the “Lee defendants,” including Thomas H. Lee Equity Partners, L.P., ML-Lee Acquisition Fund, L.P., State Street Bank and Trust Company as Trustee for the 1989 Thomas H. Lee Nominee Trust, Thomas H. Lee, Thomas R. Shepherd, John W. Childs, David V. Har-kins and Anthony DiNovi, allegedly bene-fitted from the artificially inflated price by selling all of their privately held common stock in the public offering.
On December 2, 1996, defendants moved to dismiss for failure to state a claim. Plaintiffs responded by withdrawing their complaint. On March 21, 1997, plaintiffs filed an amended complaint, and, on June 30, 1997, defendants filed a second motion to dismiss. On March 30, 1998, Judge Standish granted defendants’ motion and dismissed the complaint without leave to amend. Plaintiffs filed a timely appeal. After briefing had been completed in this court, on October 9, 1998, Judge Standish sua sponte recused himself from the matter pursuant to
The amended complaint alleged violations of sections 11, 12(a)(2), and 15 of the Securities Act of 1933 (the “Securities Act”),
We review the district court’s decision to dismiss de novo. Steamfitters Local Union No. 420 Welfare Fund v. Philiр Morris, Inc.,
As an initial matter, appellants filed a motion asking this court to vacate the judgment on appeal based on Judge Standish’s recusal and to remand the case to allow another district judge to address the motion to dismiss. However, any alleged harm to appellants is cured by our plenary review of the district court’s decision. See Bhatla v. U.S. Capital Corp.,
Appellants’ alleged claims under the Securities Act against all three sets of defendants. These claims wеre based on alleged nondisclosures in the prospectus which was a part of the registration statement filed in connection with the public offering. Section 11 of the Securities Act,
Appellants contend that the defendants violated
GNC received third-party advertising support from manufacturers of certain products who published advertisements informing consumers that these products were available at GNC stores. On appeal, appellants assert that at the time of the public offering, defendants knew that advertising support from several third-party diet product manufacturers, including Cybergenics, was declining from the prior year. As support, appellants point to a portion of the amended complaint which alleges that in January 1996, GNC officials contacted senior executives at Cybergenics with respect to “concern about [Cybergenics’] lack of sales and its potential impact on Cybergenics’ financial stability and ability to continue to provide GNC with free advertising support.” This allegation addresses only “concern” and a “potential impact” on advertising support. “Where an event is contingent or speculative in nature, it is difficult to ascertain whether the reasonable investor would have considered the omitted information significant at the time.” Shapiro,
Vitamin E is an important ingredient in many vitamin supplements marketed by GNC. The prospectus stated that GNC maintained multiple sources of all raw materials. Appellants contend that this statement was materially false and misleading because it failed to disclose the existence of a worldwide shortage of deodorized distillate, a material used to produce vitamin E. The amended complaint alleges that by the second quarter of 1995, worldwide demand for vitamin E was exceeding supply and that, after the public offering, in February 1996, GNC informed its franchisees that the shortage was adversely affecting its ability to meеt the demand for certain products containing vitamin E. Significantly, the amended complaint does not allege that the vitamin E shortage was private, internal GNC information. In fact, the amended complaint asserts that at all relevant times, the market for GNC stock was an efficient market which “promptly digested current information regarding GNC from all publicly-available sources and reflected such information in GNC’s stock price.” Federal securities laws do not require a company to state the obvious. Trump,
Appellants further allege that the prospectus failed to disclose that, at the time of the public offering, same store sales were being adversely affected by the opening of new stores in close proximity to
All of the alleged omissions are immaterial as a matter of law. We need not continue our analysis; appellants have failed to state a valid claim under
Appellants also assert claims under section 10(b) of the Exchange Act,
Appellants’ Exchange Act claims are subject to a heightened pleadings standard.
Appellants first point to a March 5, 1996 press release announcing GNC’s results for the fiscal year and fourth quarter, which ended February 3, 1996. Appellants contend that the press release was
There is nothing in the one-month passage of time from the prospectus to the press relеase that alters our finding discussed above that the worldwide vitamin E shortage and the new store openings were immaterial as a matter of law. Additionally, even if Cybergenics discontinued its third-party advertising support between March 1 and March 5, there is nothing to support an inference that GNC should or would have known by March 5 that the withdrawal would have a material effect. Appellants point out that the complaint alleges that doubling the automatic ship quantity had a “dramatic” impact on GNC’s financial results for the first fiscal quarter of 1996, which ended April 27, 1996, as a factual allegation indicating that the factor was material. However, the March 5, 1996 press release did not address this time period. In fact, the results for the first quarter of 1996 were nоt announced until May 13,1996.
Appellants further contend that defendants caused analysts to make statements which were materially false and misleading based on defendants’ statements to securities analysts on both March 5 and April 3, 1996. The first statement by analysts, that “[t]he Company remains comfortable with our [first quarter] comp[arable] projection of' 5%-6%,” allegedly resulted from a conference call which was held following the release of the March 5 report. During the conference call defendants Watts and Kozlowski stated that GNC expected comparable store sales to grow by five to six" percent in the first quarter of 1996. Appellants contend that defendants lacked a reasonable basis for making this -statement based on the three allegedly material factors that were omitted from the prospectus. However, as noted above, appellants have failed to provide factual allegations which would support a finding that these factors were material on March 5, 1996. The complaint alleges that the second set of statements were based on an April 3, 1996 meeting between GNC management and several securities analysts during which “GNC’s management” disclosed that based on existing trends, GNC’s comparable same store sales would increase by three to five percent rather than the five to six percent projected one month earlier. The complaint fails to attribute the statement to any specific member of GNC management.
The remainder of appellants’ Exchange Act claims are based on statements made after April 19, 1996, the last day on which any named plaintiff is alleged to have purchased GNC stock. Because appellants have failed to allege valid claims based on statements made before they purchased their GNC stock, the post-purchase statements cannot be a basis for liability. “[N]amed plaintiffs who represent a class must allege and show that they personally have been injured, not that injury has been suffered by other, unidentified members of the class to which they belong and which they purport to represent.” Lewis v. Casey,
Alternatively, appellants contend that the district court erred in denying them leave to amеnd their complaint. We review a district court’s denial of leave to amend a complaint for abuse of discretion. In re Burlington Coat Factory Securities Litigation,
The decision of the district court is AFFIRMED.
Notes
. The complaint alleged that the Lee defendants collectively sold all of the GNC stock that they owned in the public offering, allowing them to bail out of GNC with net proceeds in excess of $300,000,000.
. Under
. This decline in price was only temporary. By June 1997, the price had rebounded to $28.00 a share, and, on March 30, 1998, the day that Judge Standish granted the motion to dismiss, the stock was trading at approximately $38.00 a share.
. To the extent that the amended complaint alleges that prior to the public offering defendants engagеd in a scheme with Cybergenics to conceal a decline in third-party advertising support, appellants have failed to fulfill the requirements of
. Section 10(b) provides:
It shall be unlawful for any person, directly or indirectly ...
(b) To use or employ, in connection with the purchase or sale of any security ..., any manipulative or deceptive device or contrivance in contravention of such rules and regulations as the Commission may prescribe ....
Rule 10b-5 provides:
It shall be unlawful for any person, directly or indirectly, by the use of any means or instrumentality ...
(a) To employ any device, scheme, or artifice to defraud,
(b) To make any untrue statement of a material fact or to omit to state a material fact necessary in order to make the statements made, in the light of the circumstances under with they were made, not misleading, or
(c) To engage in any act, practice, or course of business which operates or would operate as a fraud or deceit upon any person,
in connection with the purchase or sale of any security.